Last reviewed · How we verify
Hepatitis B monovalent vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Hepatitis B monovalent vaccine (Hepatitis B monovalent vaccine) — University of North Carolina, Chapel Hill.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Hepatitis B monovalent vaccine TARGET | Hepatitis B monovalent vaccine | University of North Carolina, Chapel Hill | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Hepatitis B monovalent vaccine CI watch — RSS
- Hepatitis B monovalent vaccine CI watch — Atom
- Hepatitis B monovalent vaccine CI watch — JSON
- Hepatitis B monovalent vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Hepatitis B monovalent vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/hepatitis-b-monovalent-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab